Idiopathic thrombocytopenic purpura

Active Research Protocols

  1. 09-H-0199 – A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R agonist), Eltrombopag, in Patients with Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014